{"id":59393,"date":"2024-02-28T05:56:08","date_gmt":"2024-02-28T05:56:08","guid":{"rendered":"https:\/\/medsname.com\/nicerbium\/"},"modified":"2026-05-01T10:49:15","modified_gmt":"2026-05-01T10:49:15","slug":"nicerbium","status":"publish","type":"product","link":"https:\/\/medsbase.com\/da\/nicerbium\/","title":{"rendered":"Nicerbium"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Nicerbium?<\/h3>\n<p style=\"margin:0;\"><strong>Nicerbium<\/strong> er en oral <strong>nicergoline<\/strong> (30 mg) tablet \u2014 an <strong>ergot-derivative nootropic and cerebral vasodilator<\/strong> anvendt til behandling af <strong>cognitive impairment<\/strong> and symptoms of <strong>cerebrovascular insufficiency<\/strong>, including <strong>vascular dementia<\/strong>, <strong>age-related cognitive decline<\/strong>, og <strong>peripheral vascular disorders<\/strong>. It works through multiple mechanisms: &alpha;-adrenergic blockade (improving cerebral blood flow), enhancement of cholinergic and dopaminergic neurotransmission, and neuroprotective effects. Usual dose: <strong>30 mg to gange dagligt<\/strong> (or 60 mg once daily). Generally well tolerated \u2014 common side effects: mild GI upset, dizziness, flushing.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Hvad du f\u00e5r med MedsBase:<\/strong> WHO-GMP certificeret producent \u00b7 Diskret emballage \u00b7 Verdensomsp\u00e6ndende forsendelse \u00b7 1.400+ verificerede <a href=\"https:\/\/medsbase.com\/da\/reviews\/\">kundeanmeldelser<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Hver ordre er d\u00e6kket af vores <a href=\"https:\/\/medsbase.com\/da\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n<h3>Hvorfor bestille fra MedsBase<\/h3>\n<p>Vores generiske medicin kommer fra WHO-GMP certificerede producenter og sendes verdensomsp\u00e6ndende i diskret, neutral emballage \u2014 ingen medicinnavn p\u00e5 pakkens ydre. Kortbetalinger h\u00e5ndteres af en reguleret processor (kontoudtogsbeskrivelser inkluderer en reguleret betalingsprocessor \u2014 aldrig \u201cMedsBase\u201d eller medicinnavn). Crypto og SEPA bankoverf\u00f8rsel accepteres ogs\u00e5. Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy.<\/p>\n<h2 class=\"wp-block-heading\">What Is Nicerbium?<\/h2>\n<p>Nicerbium is an oral tablet containing <strong>nicergoline 30 mg<\/strong>. Nicergoline is an <strong>ergot-derived cerebral vasodilator and nootropic<\/strong> that has been in clinical use since the 1970s, primarily in Europe and Asia. It improves cerebral blood flow, enhances cholinergic and catecholaminergic neurotransmission, and has neuroprotective properties via antioxidant mechanisms.<\/p>\n<p>Nicergoline is prescribed for <strong>age-related cognitive decline<\/strong>, <strong>vascular dementia<\/strong>, <strong>chronic cerebrovascular insufficiency<\/strong>, og <strong>peripheral vascular disorders<\/strong>. It is not approved by the FDA (US) but is widely used internationally. Nicerbium is manufactured by a WHO-GMP certified facility and is bioequivalent to the originator brand <strong>Sermion<\/strong> (Pfizer).<\/p>\n<h2 class=\"wp-block-heading\">How Does Nicerbium (Nicergoline) Work?<\/h2>\n<p>Nicergoline has a <strong>multimodal mechanism<\/strong> that distinguishes it from simple vasodilators:<\/p>\n<ul>\n<li><strong>&alpha;<sub>1<\/sub>-Adrenergic receptor blockade:<\/strong> Relaxes cerebral and peripheral vascular smooth muscle, improving blood flow to the brain and extremities<\/li>\n<li><strong>Cholinergic enhancement:<\/strong> Increases acetylcholine release and inhibits acetylcholinesterase \u2014 supporting memory and cognitive function<\/li>\n<li><strong>Dopaminergic facilitation:<\/strong> Enhances dopamine turnover in the frontal cortex<\/li>\n<li><strong>Neuroprotection:<\/strong> Reduces oxidative stress, inhibits platelet aggregation, and promotes nerve growth factor (NGF) production<\/li>\n<\/ul>\n<p>These combined effects make nicergoline more than a vasodilator \u2014 it acts as a <strong>multimodal nootropic<\/strong> addressing both vascular and neurodegenerative components of cognitive decline.<\/p>\n<h2 class=\"wp-block-heading\">Indikationer<\/h2>\n<ul>\n<li><strong>Mild-to-moderate vascular dementia<\/strong> og <strong>multi-infarct dementia<\/strong><\/li>\n<li><strong>Chronic cerebrovascular insufficiency<\/strong> \u2014 dizziness, tinnitus, headache, and memory problems related to reduced cerebral blood flow<\/li>\n<li><strong>Age-related cognitive decline<\/strong> (not meeting criteria for dementia)<\/li>\n<li><strong>Peripheral vascular disorders<\/strong> \u2014 Raynaud phenomenon, intermittent claudication<\/li>\n<li><strong>Forebyggelse af migr\u00e6ne<\/strong> (adjunct, off-label in some markets)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Dosering og administration<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:0 0 24px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px 14px;\">Indikation<\/th>\n<th style=\"padding:10px 14px;\">Dosis<\/th>\n<th style=\"padding:10px 14px;\">Varighed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px 14px;\">Cognitive impairment \/ vascular dementia<\/td>\n<td style=\"padding:10px 14px;\">30 mg to gange dagligt<\/td>\n<td style=\"padding:10px 14px;\">\u22653&ndash;6 months (assess benefit at 3 months)<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px 14px;\">Cerebrovascular insufficiency<\/td>\n<td style=\"padding:10px 14px;\">30 mg twice or three times daily<\/td>\n<td style=\"padding:10px 14px;\">Ongoing as directed<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px 14px;\">Perifer vaskul\u00e6r sygdom<\/td>\n<td style=\"padding:10px 14px;\">30 mg three times daily<\/td>\n<td style=\"padding:10px 14px;\">Ongoing as directed<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Take between meals for optimal absorption (food reduces bioavailability by ~15&ndash;20%). Treatment response for cognitive symptoms typically requires <strong>at least 2&ndash;3 months<\/strong>.<\/p>\n<h2 class=\"wp-block-heading\">Bivirkninger<\/h2>\n<p><strong>Common (generally mild):<\/strong> gastric discomfort, nausea, flushing, dizziness, drowsiness, hypotension (usually postural).<\/p>\n<p><strong>Mindre almindelige:<\/strong> skin rash, insomnia, agitation, uric acid elevation (due to purine metabolite).<\/p>\n<p><strong>Rare\/serious:<\/strong> ergotism symptoms (extremely rare at therapeutic doses \u2014 nicergoline has minimal vasoconstrictive activity unlike other ergot derivatives), fibrotic reactions (very rare, class warning for ergot derivatives with prolonged use).<\/p>\n<h2 class=\"wp-block-heading\">Advarsler og forholdsregler<\/h2>\n<ul>\n<li><strong>Ergot derivative.<\/strong> Nicergoline retains weak ergot-receptor activity. Prolonged use at supratherapeutic doses carries a theoretical risk of retroperitoneal, pleural or cardiac-valve fibrosis (class effect of ergots). Standard 30 mg\/day doses have not shown clinically significant fibrosis risk in 50+ years of post-marketing surveillance.<\/li>\n<li><strong>Hypotension.<\/strong> Nicergoline is an &alpha;1-adrenoceptor antagonist &mdash; orthostatic hypotension can occur, particularly in older adults or patients on antihypertensives. Rise slowly from sitting\/lying.<\/li>\n<li><strong>Hyperuricaemia.<\/strong> Nicergoline is metabolised to nicotinic acid, which raises uric acid levels. Monitor in gout-prone patients.<\/li>\n<li><strong>Hepatic impairment.<\/strong> Nicergoline undergoes extensive first-pass hepatic metabolism. Use caution in severe liver disease.<\/li>\n<li><strong>Bleeding risk.<\/strong> Nicergoline has mild antiplatelet activity. Use caution with anticoagulants (warfarin, DOACs) and dual antiplatelet therapy.<\/li>\n<li><strong>Graviditet og amning.<\/strong> Insufficient data. Avoid unless clearly necessary.<\/li>\n<li><strong>Driving.<\/strong> Dizziness and hypotension may impair driving ability in the first 1&ndash;2 weeks.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindications &mdash; Who Should NOT Take Nicerbium<\/h2>\n<ul>\n<li>Known hypersensitivity to nicergoline, other ergot derivatives or any excipient<\/li>\n<li>Recent myocardial infarction (acute phase)<\/li>\n<li>Acute haemorrhage or active bleeding<\/li>\n<li>Severe hypotension (systolic &lt;90 mmHg)<\/li>\n<li>Severe bradycardia<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">L\u00e6gemiddelinteraktioner<\/h2>\n<ul>\n<li><strong>Antihypertensiva:<\/strong> Additive blood-pressure lowering \u2014 monitor for hypotension<\/li>\n<li><strong>Anticoagulants\/antiplatelets:<\/strong> Nicergoline inhibits platelet aggregation \u2014 theoretical additive bleeding risk<\/li>\n<li><strong>Other ergot derivatives:<\/strong> Avoid concurrent use (cumulative ergot effects)<\/li>\n<li><strong>CYP2D6 substrates:<\/strong> Nicergoline weakly inhibits CYP2D6 \u2014 clinical significance is low at standard doses<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Opbevaringsvejledning<\/h2>\n<ul>\n<li>Opbevar ved stuetemperatur, <strong>15\u201325\u00b0C<\/strong>. Beskyt mod lys og fugt.<\/li>\n<li>Keep in original packaging until use.<\/li>\n<li>Opbevar ikke i badev\u00e6relset.<\/li>\n<li>Opbevar utilg\u00e6ngeligt for b\u00f8rn.<\/li>\n<li>Brug ikke efter udl\u00f8bsdatoen.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Relaterede kategorier p\u00e5 MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/da\/neurological-conditions-and-epilepsy\/\">Se alle neurologiske og epilepsimediciner<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/heart-and-blood-pressure\/\">Browse heart &amp; blood pressure medications<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">Ofte stillede sp\u00f8rgsm\u00e5l<\/h2>\n<h3 class=\"wp-block-heading\">What is Nicerbium used for?<\/h3>\n<p>Nicerbium contains <strong>nicergoline 30 mg<\/strong> and is used to improve cognitive function and cerebral blood flow in patients with <strong>vascular dementia, chronic cerebrovascular insufficiency, and age-related cognitive decline<\/strong>.<\/p>\n<h3 class=\"wp-block-heading\">How long does nicergoline take to show benefit?<\/h3>\n<p>Cognitive improvement is gradual. Most clinical trials assessed outcomes at <strong>3\u20136 m\u00e5neder<\/strong>. Some patients notice improvements in alertness and concentration within 4&ndash;6 weeks, but meaningful cognitive changes require longer treatment.<\/p>\n<h3 class=\"wp-block-heading\">Is nicergoline effective for Alzheimer disease?<\/h3>\n<p>Nicergoline has shown modest benefit in <strong>vascular dementia<\/strong> og <strong>mixed dementia<\/strong> (vascular + Alzheimer) in Cochrane-reviewed trials. It is <strong>not a first-line treatment for pure Alzheimer disease<\/strong> \u2014 cholinesterase inhibitors (donepezil, rivastigmine) are standard of care. However, its cholinergic-enhancing and neuroprotective properties may provide adjunctive benefit in mixed-aetiology cognitive decline.<\/p>\n<h3 class=\"wp-block-heading\">Is Nicerbium the same as Sermion?<\/h3>\n<p>Both contain nicergoline. Sermion is the original brand by Pfizer (formerly Farmitalia). Nicerbium is a bioequivalent generic.<\/p>\n<h3 class=\"wp-block-heading\">Can I take nicergoline with blood pressure medications?<\/h3>\n<p>Yes, but with monitoring. Nicergoline has mild blood-pressure-lowering effects via &alpha;-blockade. Combined with antihypertensives, <strong>orthostatic hypotension<\/strong> may occur \u2014 rise slowly from sitting\/lying positions.<\/p>\n<h3 class=\"wp-block-heading\">Does nicergoline cause ergotism?<\/h3>\n<p>Extremely unlikely at therapeutic doses. Unlike ergotamine (used for migraine), nicergoline has <strong>minimal vasoconstrictive activity<\/strong>. The ergot-class fibrosis warning is retained as a precaution but has not been reported at standard nicergoline doses in clinical practice.<\/p>\n<h3 class=\"wp-block-heading\">Is nicergoline a nootropic?<\/h3>\n<p>Yes \u2014 nicergoline is classified as a <strong>nootropic<\/strong> (cognitive enhancer) in many pharmacological references. Its combination of vascular, cholinergic, and neuroprotective mechanisms distinguishes it from single-mechanism nootropics like piracetam.<\/p>\n<h3 class=\"wp-block-heading\">Can nicergoline help with tinnitus?<\/h3>\n<p>Nicergoline is prescribed for <strong>tinnitus associated with cerebrovascular insufficiency<\/strong> in some markets. It may improve tinnitus when the underlying cause is reduced blood flow to the auditory system. It is unlikely to help tinnitus from other causes (noise damage, M\u00e9ni\u00e8re disease).<\/p>\n<h3 class=\"wp-block-heading\">What are the long-term safety considerations?<\/h3>\n<p>Nicergoline has been used for <strong>decades<\/strong> with a good long-term safety profile. The main consideration is periodic monitoring of uric acid levels (nicergoline is metabolised to a purine derivative) and blood pressure.<\/p>\n<h3 class=\"wp-block-heading\">Can I drive while taking Nicerbium?<\/h3>\n<p>Nicergoline can cause mild dizziness and drowsiness, especially initially. Use caution when driving until you know how it affects you. At stable doses, most patients have no driving impairment.<\/p>\n<h3 class=\"wp-block-heading\">Does nicergoline interact with warfarin?<\/h3>\n<p>Nicergoline mildly inhibits platelet aggregation. While it does not directly affect warfarin metabolism, the additive antiplatelet effect warrants monitoring of INR if used together, particularly when starting or stopping nicergoline.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;font-size:13px;\"><strong>Medicinsk ansvarsfraskrivelse:<\/strong> Denne side er kun til informationsform\u00e5l og erstatter ikke professionel medicinsk r\u00e5dgivning. Konsult\u00e9r altid en kvalificeret sundhedsudbyder f\u00f8r du p\u00e5begynder, \u00e6ndrer eller stopper medicin. Doseringsinformation afspejler producentens m\u00e6rkning og publiceret klinisk vejledning \u2014 individuelle behov kan variere.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterede alternativer<\/h3>\n<p>Andre produkter inden for <strong>Kroniske tilstande<\/strong> som kunder ogs\u00e5 ser:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/da\/neurobion-forte-rf-injection\/\">Neurobion Forte RF-injektion (Methylcobalamin + B6 + B3) \u2014 nervereparation<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/aerocort-inhaler\/\">Aerocort Inhaler<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/arkamin\/\">Arkamin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/meftal\/\">Meftal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/temozol-20\/\">Temozol 20<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Forbedrer blodgennemstr\u00f8mning<br \/>\n\u2705 Forbedrer kognitiv funktion<br \/>\n\u2705 Reducerer vertigosymptomer<br \/>\n\u2705 Manages migraines<br \/>\n\u2705 St\u00f8tter hjernehelbred<\/p>\n<p>Nicerbium contains Nicergoline.<\/p>","protected":false},"featured_media":59394,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3468],"product_tag":[4689,4690],"class_list":{"0":"post-59393","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-neurological-conditions-and-epilepsy","9":"product_tag-nicerbium","10":"product_tag-nicergoline","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product\/59393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/comments?post=59393"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media\/59394"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media?parent=59393"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_brand?post=59393"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat?post=59393"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_tag?post=59393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}